Table 2. Medication use for responders who relapsed (R-Rel) and sustained remission (R-SustRem) at ⩾1-year follow-up.

	R-Rel (n=6)ˆ	R-SustRem (n=6)*	P-value
Allocated to FMT-D, n (%)	3 (50.0)	4 (66.6)	1.0
Concomitant drug treatment at 1-year FU, n (%)
No medication, mesalamine oral, mesalamine/corticosteroid rectal	3 (50.0)	4 (66.6)	0.57
Immunosuppressants and/or steroids <10 mg per day	2 (33.3)	2 (33.3)
Systemic corticosteroids >10 mg per day, anti-TNF	1 (16.6)	0 (0.0)

Abbreviations: Anti-TNF, antitumour necrosis factor; FU, follow-up; FMT, faecal microbiota transplantation; FMT-D, FMT with donor faeces; SCCAI, Simple Clinical Colitis Activity Index.

^*The median SCCAI scores at 1 year for patients in sustained remission were low: 0 (range 0–2).

^ˆPatients who relapsed had an SCCAI score >5 and or need for rescue therapy during FU.